A novel ex vivo high-throughput assay reveals antiproliferative effects of idelalisib and ibrutinib in chronic lymphocytic leukemia

  1. Primo, D.
  2. Scarfò, L.
  3. Xochelli, A.
  4. Mattsson, M.
  5. Ranghetti, P.
  6. Espinosa, A.B.
  7. Robles, A.
  8. Gorrochategui, J.
  9. Martínez-López, J.M.
  10. de la Serna, J.
  11. González, M.
  12. Gil, A.C.
  13. Anguita, E.
  14. Iraheta, S.
  15. Munugalavadla, V.
  16. Quéva, C.
  17. Tannheimer, S.
  18. Rosenquist, R.
  19. Stamatopoulos, K.
  20. Ballesteros, J.
  21. Ghia, P.
Revue:
Oncotarget

ISSN: 1949-2553

Année de publication: 2018

Volumen: 9

Número: 40

Pages: 26019-26031

Type: Article

DOI: 10.18632/ONCOTARGET.25419 GOOGLE SCHOLAR lock_openAccès ouvert editor
La source de données: Scopus